Botanix Pharmaceuticals Ltd (BOT) — Long-term Investment Intensity

Latest as of June 2022: 0.4%

Botanix Pharmaceuticals Ltd (BOT) has a Long-term Investment Intensity of 0.4% as of June 2022. Long-term investments of AU$61.71K represent 0.4% of total assets of AU$14.04 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check BOT asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

0.4%
LT Investments / Total Assets

Long-term Investments

AU$61.71K
AUD

Total Assets

AU$14.04 Million
AUD

Country

Australia
AU

Botanix Pharmaceuticals Ltd Long-term Investment Intensity (2020–2022)

This chart shows how Botanix Pharmaceuticals Ltd's Long-term Investment Intensity has evolved across 3 annual periods from 2020 to 2022. As of June 2022, the intensity stands at 0.4%, reflecting long-term investments of AU$61.71K against total assets of AU$14.04 Million AUD. For the complete balance sheet picture, see Botanix Pharmaceuticals Ltd balance sheet assets.

Annual Long-term Investment Intensity for Botanix Pharmaceuticals Ltd (2020–2022)

The table below presents the year-by-year Long-term Investment Intensity for Botanix Pharmaceuticals Ltd from 2020 to 2022, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read BOT current and long-term liabilities for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (AUD) Total Assets Change (pp)
2022 0.4% AU$61.71K AU$14.04 Million ▲ +0.2 pp
2021 0.3% AU$62.37K AU$21.95 Million ▼ -0.1 pp
2020 0.4% AU$88.73K AU$25.31 Million
pp = percentage points